Pharma giant Novo Nordisk discloses breach of clinical trials data

Novo Nordisk disclosed a data breach affecting pseudonymized patient data from clinical trials, including patient IDs, biomarkers, and lifestyle factors. Attackers also exposed names, emails, and phone numbers of an undisclosed number of healthcare professionals. The company took compromised systems offline but said core business operations were not impacted.